(Q38591235)
Statements
Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance (English)
S A Novosad
K L Winthrop
J W Baddley
L Calabrese
T Chiller
P Polgreen
F Bartalesi
M Lipman
X Mariette
O Lortholary
M E Weinblatt
22 September 2015